Valuation: Cencora, Inc.

Market Cap 57.3B 50.89B 47.59B 43.37B 81.65B 5,516B 82.77B 576B 223B 2,809B 215B 210B 9,024B P/E 2026 *
16.4x
P/E 2027 * 17.9x
Enterprise Value 64.99B 57.72B 53.98B 49.19B 92.61B 6,257B 93.88B 653B 253B 3,187B 244B 239B 10,235B EV / Sales 2026 *
0.19x
EV / Sales 2027 * 0.19x
Free-Float
61.21%
Yield 2026 *
0.79%
Yield 2027 * 0.81%
1 day+3.79%
1 week+1.07%
Current month+3.39%
1 month-3.89%
3 months+8.54%
6 months-0.07%
Current year-4.04%
1 week 261.3
Extreme 261.3
275.6
1 month 261.3
Extreme 261.3
290
Current year 216.4
Extreme 216.4
320.9
1 year 216.4
Extreme 216.4
325.35
3 years 169.12
Extreme 169.12
325.35
5 years 137.06
Extreme 137.06
325.35
10 years 137.06
Extreme 137.06
325.35
Manager TitleAgeSince
Chief Executive Officer 59 01/10/2024
Director of Finance/CFO 59 29/06/2026
Chief Tech/Sci/R&D Officer 50 04/11/2024
Director TitleAgeSince
Director/Board Member 75 16/05/2013
Director/Board Member 59 01/10/2024
Chairman 64 01/10/2025
Change 5-day change 1-year change 3-year change Capi.($)
+3.79%+1.07% - - 57.3B
-1.37%-3.45%-26.89%+1.93% 171B
+0.39%-2.18%-8.68%+11.33% 110B
-0.53%+1.56%-24.77%+0.04% 106B
-0.69%-0.07%-47.78%-11.65% 75.99B
+3.15%-0.08%-0.69%+72.89% 57.3B
-0.18%-0.45%-6.55%-30.78% 48.76B
+3.44%+7.90%+19.12%+59.15% 50.19B
-0.24%+1.39%-16.06%+20.79% 41.14B
+0.01%-1.29%+30.66%-8.68% 32.56B
Average +0.76%-1.46%-9.07%+12.78% 77B
Weighted average by Cap. +0.31%-2.07%-15.68%+9.98%

Financials

2026 *2027 *
Net sales 337B 299B 280B 255B 480B 32,448B 487B 3,386B 1,311B 16,525B 1,265B 1,238B 53,078B 353B 314B 293B 267B 503B 33,984B 510B 3,547B 1,373B 17,308B 1,325B 1,296B 55,591B
Net income 3.58B 3.18B 2.97B 2.71B 5.1B 345B 5.17B 35.98B 13.93B 176B 13.44B 13.15B 564B 2.84B 2.53B 2.36B 2.15B 4.05B 274B 4.11B 28.59B 11.07B 140B 10.68B 10.45B 448B
Net Debt 7.69B 6.83B 6.39B 5.82B 10.96B 740B 11.11B 77.28B 29.92B 377B 28.87B 28.25B 1,211B 9.44B 8.38B 7.84B 7.14B 13.45B 909B 13.63B 94.82B 36.71B 463B 35.43B 34.66B 1,486B
Logo Cencora, Inc.
Cencora, Inc. specializes in distributing pharmaceutical products. The group supplies generic and name-brand medications, OTC healthcare products, and home care equipment to healthcare providers (hospitals, clinics, pharmacies, physicians, etc.) located in the United States and Canada. The group also offers services to physicians and patients (support and reimbursement assistance services, prescription management services, nursing services, home injection and perfusion services, etc.).
Employees
49,000
Date Price Change
01/10/26 €274.50 +3.39%
30/09/26 €265.50 -1.67%
29/09/26 €270.00 +1.28%
28/09/26 €266.60 -0.78%
25/09/26 €268.70 -1.07%
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
300.25USD
Average target price
369.25USD
Spread / Average Target
+22.98%

Quarterly revenue - Rate of surprise